Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02637063 · ClinicalTrials.gov registry record · NA

Interactive Web Program and Health Coaching for Prehypertensive Adults

A NA study, sponsored by Oregon Center for Applied Science.

Completed
Registry status
NA
Development phase
203
Enrollment target

NCT02637063: Completed NA study, sponsored by Oregon Center for Applied Science.

NCT02637063 is a NA study that has completed, run by Oregon Center for Applied Science. The registered enrollment target is 203 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02637063, a NA study, has completed, sponsored by Oregon Center for Applied Science.

COMPLETED
Registry status
NA
Development phase
203 participants
Enrollment target

Study Summary

This project will develop and evaluate an interactive blood pressure self-management program for adults with prehypertension. The program will target blood pressure self-monitoring and the five proven lifestyle modifications recommended by JNC-7: weight reduction, the Dietary Approaches to Stop Hypertension (DASH) diet, sodium reduction, physical activity, and alcohol consumption. The multi-modal program uses a combination of brief motivational health coaching, periodic engagement emails, and a robust interactive website to motivate people to take charge of their blood pressure management before they require medication. All program components were designed to conform to the underlying principles of motivational interviewing. Key program components include the use of email and Web-based social networking, personal stories, and a brief motivational coaching session to engage participants and encourage intrinsically motivated behavior changes. Self-assessment and tracking tools are combined with educational content to help participants align their daily lifestyle choices with their personal goals. The Phase I prototype program promoted moderate physical activity and eating fruits and vegetables as part of the DASH diet. Results from the within-group (n = 39) evaluation showed moderate-to-large effect sizes for pre-to-post change in motivation, preparation behavior, self-efficacy, attitudes, and knowledge, and a small significant increase in physical activity. Participants gave the online program high ratings on satisfaction and usability, and reported improvements in confidence, readiness, clarity, change strategies, and interest in visiting the Website as a result of the coaching session. The fully developed Phase II product will be evaluated in a large randomized trial (N = 450) with a 3-month intensive intervention, a 3-month maintenance intervention, and a 3-month follow-up period. The Phase II trial is expected to show reductions in blood pressure and improveme

Primary Outcome

Blood pressure measurements were taken by participants using a validated, WIFI-enabled blood pressure cuff manufactured by BlipCare and provided to study subjects prior to the baseline assessment. Measurements were automatically uploaded over a WIFI connection to the BlipHub app and study outcomes database. Participants followed a standardized measurement protocol based on the American Heart Association protocol for home blood pressure measurement, involving three consecutive measurements, taken

Interventions

  • OTHER Usual care
  • BEHAVIORAL BlipHub mobile-web app
  • BEHAVIORAL BlipHub mobile-web app + health coaching

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2013-11
Est. Completion 2015-03
Phase NA
Oregon Center for Applied Science

14 total trials

What the finished NCT02637063 record still lists

NCT02637063 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 3 interventions - of which Usual care is the first listed.

NCT02637063 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02637063 about?

NCT02637063 is a clinical study titled "Interactive Web Program and Health Coaching for Prehypertensive Adults". This project will develop and evaluate an interactive blood pressure self-management program for adults with prehypertension. The program will target blood pressure self-monitoring and the five proven lifestyle modifications recommended by JNC-7: weight reduction, the Dietary Approaches to Stop Hype...

What is the current status of trial NCT02637063?

This trial is currently completed. It is a NA study. The enrollment target is 203 participants. The study started on 2013-11. Estimated completion is 2015-03.

What interventions are being tested in trial NCT02637063?

The interventions under investigation include: Usual care (OTHER), BlipHub mobile-web app (BEHAVIORAL), BlipHub mobile-web app + health coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT02637063?

This trial is sponsored by Oregon Center for Applied Science, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02637063's enrollment target sits among peer trials

203 504th of 2000 higher than 1,496 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05652686 · 203 participants · Phase 1

    A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

  • NCT06063122 · 203 participants · NA

    Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants

  • NCT07031245 · 203 participants · NA

    Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02637063, the US trial registry maintained by the National Library of Medicine. NCT02637063 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.